Hotline TAVI 1: extended analysis of the randomised trials
<p class="moderator speaker-name">Anchorperson: <span classs="personname">Martin Leon</span></p><p class="moderator speaker-name">Spokesperson: <span classs="personname">Ole De Backer</span></p><p class="moderator speaker-name">Discussants: <span classs="personname">Alexandre Abizaid, Michael Borger, Martine Gilard, Tanja Rudolph</span></p>
<div class="intervention"><div class="interventionTitle">The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) trial: Five-year outcomes</div><p class="speaker-intervention-name-img">William Toff</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div><p class="speaker-intervention-name-img">Michael Borger</p></div><div class="intervention"><div class="interventionTitle">Incidence, evolution, and impact of cardiac damage in asymptomatic severe aortic stenosis</div><p class="speaker-intervention-name-img">Philippe Genereux</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div><p class="speaker-intervention-name-img">Tanja Rudolph</p></div><div class="intervention"><div class="interventionTitle">One-year outcomes of contemporary TAVI valves – a randomised, non-inferiority LANDMARK trial</div><p class="speaker-intervention-name-img">Patrick Serruys</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div><p class="speaker-intervention-name-img">Alexandre Abizaid</p></div><div class="intervention"><div class="interventionTitle">Three-year results of a randomised study comparing two balloon-expandable TAVI valves</div><p class="speaker-intervention-name-img">Christian Juhl Terkelsen</p></div><div class="intervention"><div class="interventionTitle">Discussion and audience interaction</div><p class="speaker-intervention-name-img">Martine Gilard</p></div>
